Trends in Prevalence of Insulin Resistance Among Nondiabetic/Nonprediabetic Adolescents, 1999–2020
Pediatric Diabetes · 2025
DOI: 10.1155/pedi/9982025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Diabetes, 2025. Verfasst von Dongying Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Insulin Resistance, Hyperinsulinism, Prediabetic State. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Insulin resistance (IR)/hyperinsulinemia in young individuals is associated with the subsequent development of diabetes and cardiovascular disease. To assess trends in the prevalence of IR/hyperinsulinemia among nondiabetic/nonprediabetic adolescents in the US from 1999 to 2020.
Methods
A total of 6111 adolescents without diabetes and prediabetes were included from ten cycles of National Health and Nutrition Examination Survey (NHANES) between 1999–2000 and 2017–2020. Hyperinsulinemia or IR was defined as fasting insulin or homeostasis model assessment of insulin resistance [HOMA‐IR] above the 75th percentile in all participants who underwent blood tests on fasting insulin, glucose, and hemoglobin A1c. Trends in prevalence rates were estimated using joinpoint regressions with heteroscedastic and uncorrelated errors.
Results
The overall weighted median fasting insulin level, prevalence of hyperinsulinemia, and IR were 9.9 μU/ml [95% confidence interval (CI): 9.6, 10.1], 17.2% (95% CI: 15.7, 18.6), and 16.4% (95% CI: 15.2, 17.9), respectively. The estimated prevalence of hyperinsulinemia and HOMA‐IR increased significantly from 15.2% (95% CI: 12.1, 18.9) and 14.0% (95% CI: 11.1, 17.8) in 1999–2000% to 21.5% (95% CI: 17.1, 26.3) and 20.4% (95% CI: 16.4, 25.6) in 2017–2020, respectively, with a 3.35% (95% CI: 1.74, 4.99) and 3.41% (95% CI: 1.72, 5.12) relative increase per 2‐year survey cycle, respectively ( p for trend
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Obstetrics and Gynecology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Faculty of Medicine, University of Toronto, Toronto, Canada.
- Xinhua Hospital, Shanghai Institute for Pediatric Research, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Dongying Zhao, Liwei Wang, Xianting Jiao, Chutian Shi, Zhongcheng Luo, Yan Chen, Yongjun Zhang
Zitieren
APA
Zhao, D., Wang, L., Jiao, X., Shi, C., Luo, Z., Chen, Y., & Zhang, Y. (2025). Trends in Prevalence of Insulin Resistance Among Nondiabetic/Nonprediabetic Adolescents, 1999–2020. Pediatric Diabetes. https://doi.org/10.1155/pedi/9982025
Vancouver
Zhao D, Wang L, Jiao X, Shi C, Luo Z, Chen Y, et al. Trends in Prevalence of Insulin Resistance Among Nondiabetic/Nonprediabetic Adolescents, 1999–2020. Pediatric Diabetes. 2025. doi:10.1155/pedi/9982025
BibTeX
@article{Zhao2025,
author = {Zhao, Dongying and Wang, Liwei and Jiao, Xianting and Shi, Chutian and Luo, Zhongcheng and Chen, Yan and Zhang, Yongjun},
title = {Trends in Prevalence of Insulin Resistance Among Nondiabetic/Nonprediabetic Adolescents, 1999–2020},
journal = {Pediatric Diabetes},
year = {2025},
doi = {10.1155/pedi/9982025}
}
EUVIMED